Legal Representation
Attorney
Alisa C. Simmons
USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 16, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 16, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 24, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 23, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Dec 3, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 25, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 3, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 17, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 17, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 18, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 18, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 16, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 16, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 11, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 9, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 9, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 9, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 21, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 26, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 26, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 6, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 22, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2021 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 22, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 22, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 22, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Feb 3, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 3, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 3, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 27, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 13, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 12, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 4, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations, namely, medications for the treatment of dermatological conditions
Additional Information
Design Mark
The mark consists of the word "GENANI" in stylized font inside a horizontal oval egg design with the left side of the oval consisting of a DNA helix design.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005